GRAPEVINE, Texas, March 21, 2016 -- United Development Funding IV (“UDF IV” or the “Trust”) (NASDAQ:UDF) announced today that the Trust received a notification letter dated March 17, 2016 from the staff of the Listing Qualifications Department of The NASDAQ Stock Market LLC (“NASDAQ”) stating that the Trust is not in compliance with NASDAQ Listing Rule 5250(c)(1). The Rule requires timely filing of periodic reports with the Securities and Exchange Commission, and the notification letter was issued because the Trust did not timely file its Form 10-K for the year ended December 31, 2015.
UDF IV has 60 calendar days, or until May 16, 2016, to submit to NASDAQ a plan to regain compliance with the NASDAQ Listing Rules. The Trust intends to submit a plan to regain compliance within the 60-day period. Trading in UDF IV’s stock has been suspended since February 18, 2016, and no assurance can be given regarding the resumption of regular trading of the Trust’s securities.
About United Development Funding IV
United Development Funding IV is a Maryland real estate investment trust listed on The NASDAQ Global Select Market. UDF IV was formed primarily to generate current interest income by investing in secured loans and producing profits from investments in residential real estate. Additional information about UDF IV can be found on its website at www.udfiv.com. UDF IV may disseminate important information regarding its operations, including financial information, through social media platforms such as Twitter, Facebook and LinkedIn.
Contact:
| Stacey Dwyer |
| United Development Funding IV |
| [email protected] |
| Ph: 817-835-0650 |


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



